Aubrey L Shell
Overview
Explore the profile of Aubrey L Shell including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
17
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Schuiling M, Shell A, Callahan C, Nurnberger Jr J, MacDonald K, Considine R, et al.
Psychol Med
. 2024 Sep;
:1-14.
PMID: 39252547
Background: Depression is an independent risk factor for cardiovascular disease (CVD), but it is unknown if successful depression treatment reduces CVD risk. Methods: Using eIMPACT trial data, we examined the...
2.
Shell A, Crawford C, Cyders M, Hirsh A, Stewart J
J Affect Disord
. 2024 Mar;
353:70-89.
PMID: 38432462
Background: Overlapping but divided literatures suggest certain depression facets may pose greater obesity and diabetes risk than others. Our objectives were to integrate the major depressive disorder (MDD) subtype and...
3.
Crawford C, Williams M, Shell A, MacDonald K, Considine R, Wu W, et al.
Psychiatry Res
. 2023 Nov;
330:115581.
PMID: 37931480
Brain-derived neurotrophic factor (BDNF) levels are lower in people with depression and are normalized following pharmacological treatment. However, it is unknown if psychological treatments for depression improve BDNF and if...
4.
Stewart J, Patel J, Polanka B, Gao S, Nurnberger J, MacDonald K, et al.
Brain Behav Immun
. 2023 May;
112:18-28.
PMID: 37209779
Although depression is a risk and prognostic factor for cardiovascular disease (CVD), clinical trials treating depression in patients with CVD have not demonstrated cardiovascular benefits. We proposed a novel explanation...
5.
Shell A, Williams M, Patel J, Vrany E, Considine R, Acton A, et al.
J Behav Med
. 2022 Sep;
45(6):882-893.
PMID: 36074315
The somatic depressive symptom cluster (including appetite and sleep disturbances) is more strongly associated with insulin resistance (a diabetes risk marker) than other depressive symptom clusters. Utilizing baseline data from...
6.
Shell A, Gonzenbach V, Sawhney M, Crawford C, Stewart J
J Psychosom Res
. 2022 Aug;
161:110992.
PMID: 35917659
Objective: Depression is a risk factor for cardiovascular disease (CVD), and subgroups of people with depression may be at particularly elevated CVD risk. Lower high-frequency heart rate variability (HF HRV),...
7.
Shell A, Oglesby L, Um M, Stewart J, Cyders M
Eat Behav
. 2021 Oct;
43:101576.
PMID: 34689078
Negative urgency - acting rashly in response to negative emotions - is a risk factor for central adiposity. We examine whether the relationship between negative urgency and waist-to-height ratio (WHtR)...
8.
Shell A, Jackson R, Patel J, Hirsh A, Cyders M, Stewart J
Appetite
. 2021 Jul;
167:105593.
PMID: 34246713
Recent evidence suggests that atypical major depressive disorder (MDD) - whose key features include the reversed somatic symptoms of hyperphagia (increased appetite) and hypersomnia (increased sleep) - is a stronger...
9.
Shell A, Hsueh L, Vrany E, Clark D, Keith N, Xu H, et al.
J Psychosom Res
. 2020 Feb;
131:109970.
PMID: 32088427
Objective: We examined whether total depressive symptoms and symptom clusters predicted behavioral weight loss attendance among economically disadvantaged adults in a randomized controlled trial. Methods: 150 adults with obesity were...